Stock screenerAll disclosures →
EDGAR →
DNLI
Conviction 80HealthcareScan · Fri, Jun 26, 2026DNLI$25.59+3.48%
ResistanceSupportVol 14Vol MA14 2.04M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price25.59
Change+3.48%
Gap+0.53%
Rel volume2.28×
Avg volume1.94M
Avg $ vol42.86M
SMA 2021.93
SMA 5020.48
SMA 20018.61
Price vs 50+24.97%
Price vs 200+37.52%
MA stackbullish
50/200 cross—
Supertrendup · 21.53
RSI (14)76
MACD hist0.41
MACD cross—
Stoch %K / %D94 / 88
ADX (14)36
+DI / −DI32 / 7
RSI divergence—
MACD divergence—
ATR %+4.66%
ADR %5.16%
52w high25.59
52w low12.75
From 52w high+0.00%
Above 52w low+100.71%
New 52w highYes
SqueezeOff
Bollinger width36.51%
%B0.96
Donchian pos94.68%
Donchian high25.97
Donchian low18.92
AVWAP (52w high)25.26
vs AVWAP high+1.32%
AVWAP (52w low)18.92
vs AVWAP low+35.28%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d2.28×
Avg vol (14d)2.04M
Avg vol (20d)1.94M
Avg $ vol (20d)42.86M
Market cap—
RS 3m (vs SPY)-1.74%
RS 6m (vs SPY)+34.33%
RS line new highNo
Trend template7/8
Technical rank92.2
1 week+9.78%
1 month+26.62%
3 months+29.67%
6 months+52.23%
1 year+77.09%
YTD+57.28%
P/E-7.65
P/B4.24
P/S—
P/FCF-9.29
EPS-2.97
Div yield—
ROE-55.34%
ROA-40.48%
Debt/Eq—
Current9.28
EV/EBITDA-6.50
Gross margin—
Net margin—
Rev growth—
EPS growth-21.23%
Price target35.00
Target upside41.61%
Analyst ratingBuy
Institutional105.49%
Ent. value3.53B
Revenue0
Net income-128.45M
Gross profit—
Free cash flow-422.1M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out158.71M
Employees507
ListedFri, Dec 8, 2017
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank92.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance21.14
Support17.91
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DNLI
No recent disclosed trades by Congress in DNLI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DNLI · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Baker Brothers Life Sciences LP Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
BAKER JULIAN Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
BAKER FELIX Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
BAKER JULIAN Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
Baker Bros. Advisors (GP) LLC Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
BAKER BROS. ADVISORS LP Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
BAKER BROS. ADVISORS LP Director · Non-Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
Baker Brothers Life Sciences LP Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
Schenkein David P Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
Cook Jennifer E. Director · Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
SEC filings
EDGAR filings in DNLI · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.